Doctors say patients should not stop medical treatment that used the medicines to treat high blood pressure, fungal infections, and organ transplant rejection; WHO’s International Agency for Research on Cancer has placed hydrochlorothiazide, voriconazole and tacrolimus in Group 1 of the IARC Monographs